Figure 5

![Figure 5: Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity.]()

> Source: Yan Xu et al. "Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disea." *Brain and behavior*, 2020. PMID: [32441492](https://pubmed.ncbi.nlm.nih.gov/32441492/)

<figure>
  <img src="" alt="Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity." />
  <figcaption>Figure 5. Apoptosis markers in Alzheimer's disease model cells are reduced following BDMC treatment. Decreased caspase-3 activation and preserved mitochondrial membrane potential indicate anti-apoptotic activity.<br>  Source: Yan Xu et al. "Bisdemethoxycurcumin inhibits oxidative stress and antagonizes Alzheimer's disea." <em>Brain and behavior</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32441492/">32441492</a></figcaption>
</figure>